By Debdeep Gupta | 18 Sep, 2025
Cohance Life shares tumble 6% as 3.4 crore shares exchange hands via block deal
Shares of Cohance Lifesciences came under sharp pressure on September 18, tumbling 6 percent to Rs 909 apiece after a large block deal hit the exchanges. Around 3.39 crore shares, translating to 8.9 percent equity worth Rs 3,073 crore, changed hands in early trade.While the identity of sellers was not confirmed, reports on CNBC-TV18 suggested that Jusmiral Holdings was looking to offload up to 8.9...
Live Comments
anbillion 2025-06-16 13:41:02
Sun Pharma indicated that the US Food and Drug Administration (FDA) completed its inspection of its Halol plant on June 13, which resulted in a Form 483 with eight observations. The facility is still under an import alert, which was placed after a 2022 warning letter, reflecting ongoing regulatory issues.
Login & Reply Like(0) Dislike(0) Repost SpamOptionsTrade 2025-05-23 17:42:46
The company's revenue rose by 8.1%, reaching ₹12,958.8 crore, up from ₹11,982.9 crore in the prior year.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-05-19 14:00:41
Sun Pharma announced that the US FDA has approved its next-generation BLU-U blue light photodynamic therapy (PDT) for treating actinic keratosis.
Login & Reply Like(0) Dislike(0) Repost Spamanbillion 2025-04-01 11:35:30
Filed an IND application with the US FDA for SBO-154 to treat solid tumors.
Login & Reply Like(0) Dislike(0) Repost Spamblogist01 2025-02-05 09:19:08
Philogen has completed patient enrollment for the Phase III Fibrosarc trial in soft tissue sarcoma.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-02-01 09:34:09
Reported a Q3 consolidated net profit of Rs 2,900 crore, up from Rs 2,520 crore Y-o-Y, slightly beating estimates of Rs 2,880 crore. Ebitda rose to Rs 4,008 crore from Rs 3,480 crore Y-o-Y, surpassing the estimated Rs 3,700 crore. Ebitda margin improved to 29.3 per cent from 28.08 per cent Y-o-Y, exceeding the estimated 28 per cent.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-01-17 09:51:32
Sun Pharmaceutical has announced that its subsidiary, Taro Pharmaceuticals, has entered into an agreement to acquire a 100% stake in Antibe Therapeutics, a clinical-stage biotechnology company based in Ontario, Canada.
Login & Reply Like(0) Dislike(0) Repost Spamdeep1985 2023-01-23 20:43:31
stupendous breakout. no stopping till 1100. keep invested guys. happy investing.
Login & Reply Like(0) Dislike(0) Repost SpamChat_With_Sonam 2023-01-21 13:25:01
Sun Pharma acquisition of Concert Pharma is positive, says Systematix which gave Buy rating with a higher price target of 1232.
Login & Reply Like(0) Dislike(0) Repost SpamFuture&Options01 2022-09-07 14:06:09
Buy Sun Pharma for a target of 944
Login & Reply Like(0) Dislike(0) Repost SpamSIMRANTEC 2022-09-01 17:27:25
Every day rise after ce option premium eating by operator. What a fantastic stock !!!
Login & Reply Like(0) Dislike(0) Repost SpamINVESTINGPOWER 2022-09-01 11:34:59
what if it breaks 870 first
Login & Reply Like(0) Dislike(0) Repost SpamAswathigunaa01 2022-08-25 12:04:45
Ramila Buy call CE options. Today every one taken CE option for tomorrow. What will happen? Again and again premium will eat by operators.
Login & Reply Like(0) Dislike(0) Repost SpamBestStockChoice01 2022-08-24 14:34:02
Buy Sun Pharmaceutical Industries, target price Rs 1130
Login & Reply Like(0) Dislike(0) Repost SpamSONAM 21 2022-08-22 11:46:31
Pharma the weakest sector, lets watch out today!! As market is weak!
Login & Reply Like(0) Dislike(0) Repost SpamDUDU 2022-08-22 10:47:55
Today many taken 900 CE options for this expiry. Need huge premium. So Operators playing very much today. This is sunpharma.
Login & Reply Like(0) Dislike(0) Repost SpamProfitGainer01 2022-08-22 10:10:13
Take 900 PE option for huge gain tomorrow. Now 15-16, tomorrow 25, 35, 45. This expirty 55. Dont lose your money in ce option.
Login & Reply Like(0) Dislike(0) Repost SpamSanchi_Bullish_India 2022-08-20 18:46:40
promoter company . never gives return to shareholders..
Login & Reply Like(0) Dislike(0) Repost SpamOptionsTrade 2022-08-19 11:54:59
useless for CE holders . No movement even after good results, dividend etc
Login & Reply Like(0) Dislike(0) Repost SpamSEMU 2022-08-19 10:13:19
Since last month result date to till date, sunpharma favour to all future shorters. So urgent sell and immediately exit cover below 890 today monday 850. hurry sell.
Login & Reply Like(0) Dislike(0) Repost Spam